ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDUS(USD) LSE
ETF TickerIDUS.LS(USD) CXE
ETF TickerIUSA.AS(EUR) CXE
ETF TickerIUSA.DE(EUR) CXE
ETF TickerIUSA.LS(GBX) CXE
ETF TickerIUSA.MI(EUR) CXE
ETF TickerIUSAz(USD) CXE
ETF TickerIUSA(EUR) ETF Plus
ETF TickerIDUS.L(GBP) LSE

Holdings detail for CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO
(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price
In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades
Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares Core S&P 500 UCITS ETF USD (Dist) CRL holdings

DateNumber of CRL Shares HeldBase Market Value of CRL SharesLocal Market Value of CRL SharesChange in CRL Shares HeldChange in CRL Base ValueCurrent Price per CRL Share HeldPrevious Price per CRL Share Held
2025-12-02 (Tuesday)17,123USD 2,992,415CRL holding decreased by -22774USD 2,992,4150USD -22,774 USD 174.76 USD 176.09
2025-12-01 (Monday)17,123CRL holding decreased by -7USD 3,015,189CRL holding decreased by -34808USD 3,015,189-7USD -34,808 USD 176.09 USD 178.05
2025-11-25 (Tuesday)17,130CRL holding decreased by -63USD 3,049,997CRL holding increased by 119622USD 3,049,997-63USD 119,622 USD 178.05 USD 170.44
2025-11-24 (Monday)17,193USD 2,930,375CRL holding increased by 48140USD 2,930,3750USD 48,140 USD 170.44 USD 167.64
2025-11-21 (Friday)17,193CRL holding decreased by -7USD 2,882,235CRL holding increased by 94459USD 2,882,235-7USD 94,459 USD 167.64 USD 162.08
2025-11-20 (Thursday)17,200USD 2,787,776CRL holding increased by 7568USD 2,787,7760USD 7,568 USD 162.08 USD 161.64
2025-11-19 (Wednesday)17,200CRL holding decreased by -14USD 2,780,208CRL holding decreased by -17583USD 2,780,208-14USD -17,583 USD 161.64 USD 162.53
2025-11-18 (Tuesday)17,214CRL holding decreased by -21USD 2,797,791CRL holding decreased by -7033USD 2,797,791-21USD -7,033 USD 162.53 USD 162.74
2025-11-17 (Monday)17,235CRL holding decreased by -28USD 2,804,824CRL holding decreased by -116248USD 2,804,824-28USD -116,248 USD 162.74 USD 169.21
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE0031442068

Show aggregate share trades of CRL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-01SELL-7180.950175.710 176.234GBX -1,234 161.76 Loss of -101 on sale
2025-11-25SELL-63178.540170.780 171.556GBX -10,808 161.68 Loss of -622 on sale
2025-11-21SELL-7172.390157.490 158.980GBX -1,113 161.62 Profit of 18 on sale
2025-11-19SELL-14161.955156.790 157.306GBX -2,202 161.61 Profit of 60 on sale
2025-11-18SELL-21164.335160.490 160.875GBX -3,378 161.61 Profit of 15 on sale
2025-11-17SELL-28169.995162.720 163.448GBX -4,577 161.61 Loss of -52 on sale
2025-11-13SELL-56175.100168.275 168.957GBX -9,462 161.57 Loss of -414 on sale
2025-11-11SELL-14175.550167.600 168.395GBX -2,358 161.52 Loss of -96 on sale
2025-11-10SELL-42172.830166.960 167.547GBX -7,037 161.48 Loss of -255 on sale
2025-11-06SELL-14175.000165.740 166.666GBX -2,333 161.44 Loss of -73 on sale
2025-11-04SELL-28180.185175.827 176.262GBX -4,935 161.36 Loss of -417 on sale
2025-10-22SELL-7187.000190.690 190.321GBX -1,332 161.24 Loss of -204 on sale
2025-10-21SELL-14188.260190.410 190.195GBX -2,663 161.11 Loss of -407 on sale
2025-10-16BUY7174.950177.750 177.470GBX 1,242 161.05
2025-10-14SELL-21170.130172.410 172.182GBX -3,616 160.96 Loss of -236 on sale
2025-10-13SELL-28170.640172.210 172.053GBX -4,817 160.91 Loss of -312 on sale
2025-09-25BUY7145.570148.390 148.108GBX 1,037 160.99
2025-09-24SELL-21149.450150.870 150.728GBX -3,165 161.04 Profit of 217 on sale
2025-09-18BUY7156.990157.630 157.566GBX 1,103 161.07
2025-09-17BUY7152.720157.010 156.581GBX 1,096 161.11
2025-08-19SELL-14158.480160.000 159.848GBX -2,238 161.21 Profit of 19 on sale
2025-08-15SELL-7156.680158.160 158.012GBX -1,106 161.26 Profit of 23 on sale
2025-08-13SELL-35155.000155.430 155.387GBX -5,439 161.29 Profit of 207 on sale
2025-08-12SELL-91152.750154.010 153.884GBX -14,003 161.33 Profit of 678 on sale
2025-08-07SELL-105149.780154.980 154.460GBX -16,218 161.39 Profit of 728 on sale
2025-08-05BUY7167.490168.330 168.246GBX 1,178 161.42
2025-07-31BUY21169.640176.150 175.499GBX 3,685 161.38
2025-07-28BUY7178.990180.440 180.295GBX 1,262 161.11
2025-07-25SELL-14176.930177.570 177.506GBX -2,485 161.02 Loss of -231 on sale
2025-07-22SELL-863163.360167.830 167.383GBX -144,452 160.97 Loss of -5,534 on sale
2025-07-18BUY7154.480158.180 157.810GBX 1,105 161.07
2025-07-14SELL-7158.040160.410 160.173GBX -1,121 161.18 Profit of 7 on sale
2025-07-08SELL-14158.390160.000 159.839GBX -2,238 161.20 Profit of 19 on sale
2025-07-02BUY42157.490158.380 158.291GBX 6,648 161.31
2025-06-24SELL-14148.400149.680 149.552GBX -2,094 161.64 Profit of 169 on sale
2025-06-23SELL-7147.380148.320 148.226GBX -1,038 161.73 Profit of 95 on sale
2025-06-20SELL-42147.450147.740 147.711GBX -6,204 161.82 Profit of 593 on sale
2025-06-12SELL-21151.890152.640 152.565GBX -3,204 162.20 Profit of 202 on sale
2025-06-06BUY7144.700145.650 145.555GBX 1,019 162.55
2025-06-02SELL-21135.040135.440 135.400GBX -2,843 163.17 Profit of 583 on sale
2025-05-29SELL-7137.700138.600 138.510GBX -970 163.53 Profit of 175 on sale
2025-05-27BUY7138.650140.650 140.450GBX 983 163.88
2025-05-23BUY7136.730137.000 136.973GBX 959 164.26
2025-05-21SELL-21134.980141.710 141.037GBX -2,962 164.67 Profit of 496 on sale
2025-05-15BUY28138.890139.380 139.331GBX 3,901 165.35
2025-05-14SELL-42138.950146.430 145.682GBX -6,119 165.54 Profit of 834 on sale
2025-05-13SELL-84144.020145.640 145.478GBX -12,220 165.70 Profit of 1,699 on sale
2025-05-07SELL-21136.970144.770 143.990GBX -3,024 166.48 Profit of 472 on sale
2025-05-02SELL-7118.460121.810 121.475GBX -850 167.61 Profit of 323 on sale
2025-04-29SELL-21117.290117.860 117.803GBX -2,474 168.80 Profit of 1,071 on sale
2025-04-24BUY7115.760115.940 115.922GBX 811 170.11
2025-04-22BUY28106.890107.290 107.250GBX 3,003 171.14
2025-04-16BUY7104.250107.230 106.932GBX 749 173.41
2025-04-15BUY7105.920107.580 107.414GBX 752 173.99
2025-04-11BUY1499.750101.360 101.199GBX 1,417 175.23
2025-04-09BUY35139.070139.310 139.286GBX 4,875 176.22
2025-04-08BUY105123.610137.960 136.525GBX 14,335 176.70
2025-04-07SELL-49134.070139.160 138.651GBX -6,794 177.09 Profit of 1,883 on sale
2025-04-04SELL-105136.900140.150 139.825GBX -14,682 177.45 Profit of 3,951 on sale
2025-04-02SELL-21149.280150.160 150.072GBX -3,152 177.72 Profit of 581 on sale
2025-04-01SELL-7145.990151.370 150.832GBX -1,056 178.01 Profit of 190 on sale
2025-03-31SELL-14150.520153.820 153.490GBX -2,149 178.27 Profit of 347 on sale
2025-03-28BUY14155.550158.710 158.394GBX 2,218 178.49
2025-03-25BUY21161.350168.000 167.335GBX 3,514 179.05
2025-03-24BUY28166.980169.260 169.032GBX 4,733 179.17
2025-03-21SELL-14167.280167.940 167.874GBX -2,350 179.29 Profit of 160 on sale
2025-03-20BUY14165.350171.710 171.074GBX 2,395 179.43
2025-03-19BUY28173.880178.810 178.317GBX 4,993 179.49
2025-03-17SELL-21175.010175.600 175.541GBX -3,686 179.56 Profit of 84 on sale
2025-03-14SELL-14171.040171.630 171.571GBX -2,402 179.65 Profit of 113 on sale
2025-03-13SELL-42166.930172.250 171.718GBX -7,212 179.79 Profit of 339 on sale
2025-03-11SELL-49166.630175.070 174.226GBX -8,537 180.03 Profit of 284 on sale
2025-03-10SELL-28175.120181.440 180.808GBX -5,063 180.09 Loss of -20 on sale
2025-03-06SELL-28169.270170.610 170.476GBX -4,773 180.25 Profit of 274 on sale
2025-03-05SELL-42167.550167.990 167.946GBX -7,054 180.40 Profit of 523 on sale
2025-03-04SELL-56164.310166.710 166.470GBX -9,322 180.58 Profit of 790 on sale
2025-02-28SELL-35165.310165.820 165.769GBX -5,802 180.96 Profit of 532 on sale
2025-02-26BUY14167.960170.440 170.192GBX 2,383 181.31
2025-02-24BUY14170.510172.450 172.256GBX 2,412 181.62
2025-02-21BUY7163.020165.050 164.847GBX 1,154 181.86
2025-02-20SELL-21162.250168.020 167.443GBX -3,516 182.10 Profit of 308 on sale
2025-02-14SELL-7151.990155.020 154.717GBX -1,083 183.50 Profit of 202 on sale
2025-02-13SELL-91153.170155.290 155.078GBX -14,112 183.91 Profit of 2,624 on sale
2025-02-12SELL-7154.000154.730 154.657GBX -1,083 184.32 Profit of 208 on sale
2025-02-06SELL-28166.270168.840 168.583GBX -4,720 185.66 Profit of 478 on sale
2025-02-05BUY7165.870166.120 166.095GBX 1,163 185.96
2025-02-04BUY49163.120169.670 169.015GBX 8,282 186.30
2025-01-29SELL-49161.640163.000 162.864GBX -7,980 187.75 Profit of 1,219 on sale
2025-01-28BUY14163.640167.470 167.087GBX 2,339 188.14
2025-01-24BUY7164.970168.150 167.832GBX 1,175 188.90
2025-01-22BUY14168.220170.830 170.569GBX 2,388 189.63
2025-01-16BUY14165.800168.620 168.338GBX 2,357 191.41
2025-01-15BUY7173.910182.250 181.416GBX 1,270 191.74
2025-01-10BUY14186.120188.260 188.046GBX 2,633 192.16
2025-01-02BUY21182.640187.320 186.852GBX 3,924 192.54
2024-12-31BUY14184.600185.980 185.842GBX 2,602 192.71
2024-12-27BUY7186.160188.320 188.104GBX 1,317 193.07
2024-12-20BUY21185.770188.040 187.813GBX 3,944 193.78
2024-12-19BUY7182.150185.050 184.760GBX 1,293 194.08
2024-12-18SELL-7183.160191.610 190.765GBX -1,335 194.36 Profit of 25 on sale
2024-12-17BUY14189.330199.450 198.438GBX 2,778 194.50
2024-12-13BUY7190.460194.170 193.799GBX 1,357 194.74
2024-12-10BUY7197.050202.720 202.153GBX 1,415 194.71
2024-12-06SELL-14191.810195.370 195.014GBX -2,730 194.57 Loss of -6 on sale
2024-12-05BUY7191.540198.830 198.101GBX 1,387 194.67
2024-12-04SELL-56199.350201.420 201.213GBX -11,268 194.51 Loss of -375 on sale
2024-12-03BUY21199.300201.120 200.938GBX 4,220 194.34
2024-12-02BUY35201.250203.010 202.834GBX 7,099 194.09
2024-11-27BUY7199.590202.560 202.263GBX 1,416 193.42
2024-11-26BUY49197.750200.200 199.955GBX 9,798 193.23
2024-11-21BUY21194.190194.880 194.811GBX 4,091 192.65
2024-11-20BUY14187.900188.320 188.278GBX 2,636 192.90
2024-11-19BUY7186.100188.380 188.152GBX 1,317 193.28
2024-11-18BUY14187.500187.930 187.887GBX 2,630 193.62
2024-11-12BUY28215.940221.600 221.034GBX 6,189 192.23
2024-11-11BUY14220.690222.100 221.959GBX 3,107 190.33
2024-11-08BUY56215.390216.150 216.074GBX 12,100 188.54
2024-11-07BUY49210.290217.600 216.869GBX 10,627 186.87
2024-11-06BUY56214.200230.020 228.438GBX 12,793 184.59
2024-11-05SELL-14188.680189.180 189.130GBX -2,648 184.22 Loss of -69 on sale
2024-11-04BUY14182.480185.860 185.522GBX 2,597 184.39
2024-11-01BUY49180.960184.040 183.732GBX 9,003 184.77
2024-10-28BUY35186.520188.000 187.852GBX 6,575 186.49
2024-10-25BUY77182.120184.550 184.307GBX 14,192 187.58
2024-10-23SELL-7186.630188.060 187.917GBX -1,315 190.49 Profit of 18 on sale
2024-10-21BUY7195.040197.640 197.380GBX 1,382 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,1391131,07574.9%
2025-09-1862,9972121,43651.9%
2025-09-1792,1290727,00512.7%
2025-09-16115,39612317,67336.3%
2025-09-1566,3561151,09343.9%
2025-09-1277,5570176,81743.9%
2025-09-1187,9991204,23743.1%
2025-09-10122,6560398,56430.8%
2025-09-09125,4020471,64226.6%
2025-09-08178,3420414,72943.0%
2025-09-0576,2640192,66839.6%
2025-09-0494,7920179,53352.8%
2025-09-03139,6460216,26564.6%
2025-09-02112,81930183,91061.3%
2025-08-29105,9651,040180,20658.8%
2025-08-28183,9714248,97873.9%
2025-08-2771,8910134,03453.6%
2025-08-26109,85319166,15266.1%
2025-08-25147,16623300,78148.9%
2025-08-22251,1260414,08560.6%
2025-08-21102,1520149,37668.4%
2025-08-20152,7210215,94670.7%
2025-08-19118,8310172,88768.7%
2025-08-1893,0280164,64156.5%
2025-08-1596,5001180,16553.6%
2025-08-14147,9520251,45658.8%
2025-08-13820,20601,075,15376.3%
2025-08-12299,3220438,69968.2%
2025-08-11192,9170365,05852.8%
2025-08-0892,08966222,12841.5%
2025-08-07326,647522550,23059.4%
2025-08-06532,4347,827888,87359.9%
2025-08-05283,1486539,93852.4%
2025-08-04124,11154248,83449.9%
2025-08-01162,441300281,62257.7%
2025-07-31125,6480228,70654.9%
2025-07-30115,4870188,12161.4%
2025-07-29181,1590275,84365.7%
2025-07-28198,89649321,94161.8%
2025-07-25162,642111293,83155.4%
2025-07-24385,658456820,47247.0%
2025-07-23150,6500346,02043.5%
2025-07-22205,73626821,85325.0%
2025-07-21132,794101445,92029.8%
2025-07-1893,150207186,54249.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy